A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, multicenter study designed to assess
the safety and efficacy of PPC-06 (tepilamide fumarate) extended release in subjects with
moderate-to-severe plaque psoriasis.